 | | QSK | | Name: | [(2~{R},3~{R},4~{R},5~{R})-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-4-(trifluoromethyloxy)oxolan-2-yl]methoxyphosphinic acid | | Formula: | C10 H13 F3 N3 O7 P | | SMILES: | NC1=NC(=O)N(C=C1)[CH]2O[CH](CO[PH](O)=O)[CH](O)[CH]2OC(F)(F)F | | InChi: | InChI=1S/C10H13F3N3O7P/c11-10(12,13)23-7-6(17)4(3-21-24(19)20)22-8(7)16-2-1-5(14)15-9(16)18/h1-2,4,6-8,17,24H,3H2,(H,19,20)(H2,14,15,18)/t4-,6-,7-,8-/m1/s1 | | Definition date: | 2020-07-31 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | [(2~{R},3~{R},4~{R},5~{R})-5-(4-azanyl-2-oxidanylidene-pyrimidin-1-yl)-3-oxidanyl-4-(trifluoromethyloxy)oxolan-2-yl]methoxyphosphinic acid |
|
 | | QSQ | | Name: | [(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-(trifluoromethyloxy)oxolan-2-yl]methyl dihydrogen phosphite | | Formula: | C11 H13 F3 N5 O6 P | | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](COP(O)O)[CH](O)[CH]3OC(F)(F)F | | InChi: | InChI=1S/C11H13F3N5O6P/c12-11(13,14)25-7-6(20)4(1-23-26(21)22)24-10(7)19-3-18-5-8(15)16-2-17-9(5)19/h2-4,6-7,10,20-22H,1H2,(H2,15,16,17)/t4-,6-,7-,10-/m1/s1 | | Definition date: | 2020-07-31 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | [(2~{R},3~{R},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3-oxidanyl-4-(trifluoromethyloxy)oxolan-2-yl]methyl dihydrogen phosphite |
|
 | | QTA | | Name: | 3-(phenylsulfonyl)benzene-1-sulfonamide | | Formula: | C12 H11 N O4 S2 | | SMILES: | c1(cc(S(N)(=O)=O)ccc1)S(c2ccccc2)(=O)=O | | InChi: | InChI=1S/C12H11NO4S2/c13-19(16,17)12-8-4-7-11(9-12)18(14,15)10-5-2-1-3-6-10/h1-9H,(H2,13,16,17) | | Definition date: | 2019-12-18 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 3-(phenylsulfonyl)benzene-1-sulfonamide |
|
 | | R9Q | | Name: | 3-[(2~{R})-4-methyl-5-oxidanylidene-2,3-dihydro-1,4-benzoxazepin-2-yl]benzenecarbonitrile | | Formula: | C17 H14 N2 O2 | | SMILES: | CN1C[CH](Oc2ccccc2C1=O)c3cccc(c3)C#N | | InChi: | InChI=1S/C17H14N2O2/c1-19-11-16(13-6-4-5-12(9-13)10-18)21-15-8-3-2-7-14(15)17(19)20/h2-9,16H,11H2,1H3/t16-/m0/s1 | | Definition date: | 2020-09-21 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 3-[(2~{R})-4-methyl-5-oxidanylidene-2,3-dihydro-1,4-benzoxazepin-2-yl]benzenecarbonitrile |
|
 | | G6C | | Name: | 5-oxidanyl-1H-pyridin-2-one | | Formula: | C5 H5 N O2 | | SMILES: | OC1=CNC(=O)C=C1 | | InChi: | InChI=1S/C5H5NO2/c7-4-1-2-5(8)6-3-4/h1-3,7H,(H,6,8) | | Definition date: | 2020-07-31 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 5-oxidanyl-1~{H}-pyridin-2-one |
|
 | | D6O | | Name: | (~{Z})-4-formamido-4-oxidanylidene-but-2-enoic acid | | Formula: | C5 H5 N O4 | | SMILES: | OC(=O)C=CC(=O)NC=O | | InChi: | InChI=1S/C5H5NO4/c7-3-6-4(8)1-2-5(9)10/h1-3H,(H,9,10)(H,6,7,8)/b2-1- | | Definition date: | 2019-07-11 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (~{Z})-4-formamido-4-oxidanylidene-but-2-enoic acid |
|
 | | EDF | | Name: | (3~{R})-1,3-dimethyl-6-[(4-phenylpyrimidin-2-yl)amino]-4-propan-2-yl-3~{H}-quinoxalin-2-one | | Formula: | C23 H25 N5 O | | SMILES: | CC(C)N1[CH](C)C(=O)N(C)c2ccc(Nc3nccc(n3)c4ccccc4)cc12 | | InChi: | InChI=1S/C23H25N5O/c1-15(2)28-16(3)22(29)27(4)20-11-10-18(14-21(20)28)25-23-24-13-12-19(26-23)17-8-6-5-7-9-17/h5-16H,1-4H3,(H,24,25,26)/t16-/m1/s1 | | Definition date: | 2019-12-13 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (3~{R})-1,3-dimethyl-6-[(4-phenylpyrimidin-2-yl)amino]-4-propan-2-yl-3~{H}-quinoxalin-2-one |
|
 | | EE6 | | Name: | 3-[3-(3-methylbut-2-enyl)-4-oxidanyl-phenyl]-5-[[3-(3-methylbut-2-enyl)-4-oxidanyl-phenyl]methylidene]-4-oxidanyl-furan-2-one | | Formula: | C27 H28 O5 | | SMILES: | CC(C)=CCc1cc(ccc1O)C=C2OC(=O)C(=C2O)c3ccc(O)c(CC=C(C)C)c3 | | InChi: | InChI=1S/C27H28O5/c1-16(2)5-8-19-13-18(7-11-22(19)28)14-24-26(30)25(27(31)32-24)21-10-12-23(29)20(15-21)9-6-17(3)4/h5-7,10-15,28-30H,8-9H2,1-4H3 | | Definition date: | 2019-12-13 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 3-[3-(3-methylbut-2-enyl)-4-oxidanyl-phenyl]-5-[[3-(3-methylbut-2-enyl)-4-oxidanyl-phenyl]methylidene]-4-oxidanyl-furan-2-one |
|
 | | EE9 | | Name: | (3~{R})-6-[(4-isoquinolin-4-ylpyrimidin-2-yl)amino]-1,3-dimethyl-4-propan-2-yl-3~{H}-quinoxalin-2-one | | Formula: | C26 H26 N6 O | | SMILES: | CC(C)N1[CH](C)C(=O)N(C)c2ccc(Nc3nccc(n3)c4cncc5ccccc45)cc12 | | InChi: | InChI=1S/C26H26N6O/c1-16(2)32-17(3)25(33)31(4)23-10-9-19(13-24(23)32)29-26-28-12-11-22(30-26)21-15-27-14-18-7-5-6-8-20(18)21/h5-17H,1-4H3,(H,28,29,30)/t17-/m1/s1 | | Definition date: | 2019-12-13 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (3~{R})-6-[(4-isoquinolin-4-ylpyrimidin-2-yl)amino]-1,3-dimethyl-4-propan-2-yl-3~{H}-quinoxalin-2-one |
|
 | | EEL | | Name: | (2R)-1-[3-sulfanyl-2-(sulfanylmethyl)propanoyl]pyrrolidine-2-carboxylic acid | | Formula: | C9 H15 N O3 S2 | | SMILES: | OC(=O)[CH]1CCCN1C(=O)C(CS)CS | | InChi: | InChI=1S/C9H15NO3S2/c11-8(6(4-14)5-15)10-3-1-2-7(10)9(12)13/h6-7,14-15H,1-5H2,(H,12,13)/t7-/m1/s1 | | Definition date: | 2019-12-16 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (2~{R})-1-[3-sulfanyl-2-(sulfanylmethyl)propanoyl]pyrrolidine-2-carboxylic acid |
|
 | | EEO | | Name: | (2R)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]azepane-2-carboxylic acid | | Formula: | C11 H19 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCCCC[CH]1C(O)=O | | InChi: | InChI=1S/C11H19NO3S/c1-8(7-16)10(13)12-6-4-2-3-5-9(12)11(14)15/h8-9,16H,2-7H2,1H3,(H,14,15)/t8-,9-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (2~{R})-1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]azepane-2-carboxylic acid |
|
 | | EER | | Name: | (2R)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidine-2-carboxylic acid | | Formula: | C10 H17 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCCC[CH]1C(O)=O | | InChi: | InChI=1S/C10H17NO3S/c1-7(6-15)9(12)11-5-3-2-4-8(11)10(13)14/h7-8,15H,2-6H2,1H3,(H,13,14)/t7-,8-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (2~{R})-1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidine-2-carboxylic acid |
|
 | | EEX | | Name: | (1R)-2-[(2S)-2-methyl-3-sulfanyl-propanoyl]-3,4-dihydro-1H-isoquinoline-1-carboxylic acid | | Formula: | C14 H17 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCc2ccccc2[CH]1C(O)=O | | InChi: | InChI=1S/C14H17NO3S/c1-9(8-19)13(16)15-7-6-10-4-2-3-5-11(10)12(15)14(17)18/h2-5,9,12,19H,6-8H2,1H3,(H,17,18)/t9-,12-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (1~{R})-2-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]-3,4-dihydro-1~{H}-isoquinoline-1-carboxylic acid |
|
 | | EF0 | | Name: | 1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidine-4-carboxylic acid | | Formula: | C10 H17 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCC(CC1)C(O)=O | | InChi: | InChI=1S/C10H17NO3S/c1-7(6-15)9(12)11-4-2-8(3-5-11)10(13)14/h7-8,15H,2-6H2,1H3,(H,13,14)/t7-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidine-4-carboxylic acid |
|
 | | EF9 | | Name: | (3S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidine-3-carboxylic acid | | Formula: | C10 H17 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCC[CH](C1)C(O)=O | | InChi: | InChI=1S/C10H17NO3S/c1-7(6-15)9(12)11-4-2-3-8(5-11)10(13)14/h7-8,15H,2-6H2,1H3,(H,13,14)/t7-,8+/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (3~{S})-1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidine-3-carboxylic acid |
|
 | | EFF | | Name: | 1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidine-4-carboxamide | | Formula: | C10 H18 N2 O2 S | | SMILES: | C[CH](CS)C(=O)N1CCC(CC1)C(N)=O | | InChi: | InChI=1S/C10H18N2O2S/c1-7(6-15)10(14)12-4-2-8(3-5-12)9(11)13/h7-8,15H,2-6H2,1H3,(H2,11,13)/t7-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidine-4-carboxamide |
|
 | | EFR | | Name: | 2-[1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidin-4-yl]ethanamide | | Formula: | C11 H20 N2 O2 S | | SMILES: | C[CH](CS)C(=O)N1CCC(CC1)CC(N)=O | | InChi: | InChI=1S/C11H20N2O2S/c1-8(7-16)11(15)13-4-2-9(3-5-13)6-10(12)14/h8-9,16H,2-7H2,1H3,(H2,12,14)/t8-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 2-[1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidin-4-yl]ethanamide |
|
 | | GXO | | Name: | [1,1,1-tris(fluoranyl)-2-methyl-propan-2-yl] ~{N}-[(1~{S},4~{R},6~{S},7~{Z},11~{R},13~{R},14~{S},18~{R})-13-ethyl-18-(7-fluoranyl-6-methoxy-isoquinolin-1-yl)oxy-11-methyl-4-[(1-methylcyclopropyl)sulfonylcarbamoyl]-2,15-bis(oxidanylidene)-3,16-diazatricyclo[14.3.0.0^{4,6}]nonadec-7-en-14-yl]carbamate | | Formula: | C40 H51 F4 N5 O9 S | | SMILES: | CC[CH]1C[CH](C)CCC=C[CH]2C[C]2(NC(=O)[CH]3C[CH](CN3C(=O)[CH]1NC(=O)OC(C)(C)C(F)(F)F)Oc4nccc5cc(OC)c(F)cc45)C(=O)N[S](=O)(=O)C6(C)CC6 | | InChi: | InChI=1S/C40H51F4N5O9S/c1-7-23-16-22(2)10-8-9-11-25-20-39(25,35(52)48-59(54,55)38(5)13-14-38)47-32(50)29-18-26(57-33-27-19-28(41)30(56-6)17-24(27)12-15-45-33)21-49(29)34(51)31(23)46-36(53)58-37(3,4)40(42,43)44/h9,11-12,15,17,19,22-23,25-26,29,31H,7-8,10,13-14,16,18,20-21H2,1-6H3,(H,46,53)(H,47,50)(H,48,52)/b11-9-/t22-,23-,25-,26-,29+,31+,39-/m1/s1 | | Definition date: | 2020-10-06 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | [1,1,1-tris(fluoranyl)-2-methyl-propan-2-yl] ~{N}-[(1~{S},4~{R},6~{S},7~{Z},11~{R},13~{R},14~{S},18~{R})-13-ethyl-18-(7-fluoranyl-6-methoxy-isoquinolin-1-yl)oxy-11-methyl-4-[(1-methylcyclopropyl)sulfonylcarbamoyl]-2,15-bis(oxidanylidene)-3,16-diazatricyclo[14.3.0.0^{4,6}]nonadec-7-en-14-yl]carbamate |
|
 | | DS9 | | Name: | (2R)-14-fluoro-2-methyl-6,9,10,19-tetrazapentacyclo[14.2.1.02,6.08,18.012,17]nonadeca-1(18),8,12(17),13,15-pentaen-11-one | | Formula: | C16 H15 F N4 O | | SMILES: | C[C]12CCCN1CC3=NNC(=O)c4cc(F)cc5[nH]c2c3c45 | | InChi: | InChI=1S/C16H15FN4O/c1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16/h5-6,18H,2-4,7H2,1H3,(H,20,22)/t16-/m1/s1 | | Definition date: | 2019-08-23 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 |
|
 | | L2Z | | Name: | ~{N}-[2-methoxy-5-(2-oxa-6-azaspiro[3.3]heptan-6-ylsulfonyl)phenyl]-3-methyl-4-oxidanylidene-5,6,7,8-tetrahydro-2~{H}-cyclohepta[c]pyrrole-1-carboxamide | | Formula: | C23 H27 N3 O6 S | | SMILES: | COc1ccc(cc1NC(=O)c2[nH]c(C)c3C(=O)CCCCc23)[S](=O)(=O)N4CC5(COC5)C4 | | InChi: | InChI=1S/C23H27N3O6S/c1-14-20-16(5-3-4-6-18(20)27)21(24-14)22(28)25-17-9-15(7-8-19(17)31-2)33(29,30)26-10-23(11-26)12-32-13-23/h7-9,24H,3-6,10-13H2,1-2H3,(H,25,28) | | Definition date: | 2019-07-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | ~{N}-[2-methoxy-5-(2-oxa-6-azaspiro[3.3]heptan-6-ylsulfonyl)phenyl]-3-methyl-4-oxidanylidene-5,6,7,8-tetrahydro-2~{H}-cyclohepta[c]pyrrole-1-carboxamide |
|
 | | EG0 | | Name: | 2-[1-[(2S)-2-methyl-3-sulfanyl-propanoyl]piperidin-4-yl]ethanoic acid | | Formula: | C11 H19 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCC(CC1)CC(O)=O | | InChi: | InChI=1S/C11H19NO3S/c1-8(7-16)11(15)12-4-2-9(3-5-12)6-10(13)14/h8-9,16H,2-7H2,1H3,(H,13,14)/t8-/m1/s1 | | Definition date: | 2019-12-17 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | 2-[1-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]piperidin-4-yl]ethanoic acid |
|
 | | EKX | | Name: | (1S)-2-[(2S)-2-methyl-3-sulfanyl-propanoyl]-3,4-dihydro-1H-isoquinoline-1-carboxylic acid | | Formula: | C14 H17 N O3 S | | SMILES: | C[CH](CS)C(=O)N1CCc2ccccc2[CH]1C(O)=O | | InChi: | InChI=1S/C14H17NO3S/c1-9(8-19)13(16)15-7-6-10-4-2-3-5-11(10)12(15)14(17)18/h2-5,9,12,19H,6-8H2,1H3,(H,17,18)/t9-,12+/m1/s1 | | Definition date: | 2020-01-09 | | Last modified: | 2020-12-11 | | Release date: | 2020-12-16 | | Identifier: | (1~{S})-2-[(2~{S})-2-methyl-3-sulfanyl-propanoyl]-3,4-dihydro-1~{H}-isoquinoline-1-carboxylic acid |
|
 | | WCS | | Name: | 6-{4-[3-(dimethylamino)propoxy]phenyl}-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]pyrimidin-4-amine | | Formula: | C22 H30 N6 O3 S | | SMILES: | c1(ccc(cc1)OCCCN(C)C)c2nc(S(C)(=O)=O)nc(c2)NCCCn3cccn3 | | InChi: | InChI=1S/C22H30N6O3S/c1-27(2)13-6-16-31-19-9-7-18(8-10-19)20-17-21(26-22(25-20)32(3,29)30)23-11-4-14-28-15-5-12-24-28/h5,7-10,12,15,17H,4,6,11,13-14,16H2,1-3H3,(H,23,25,26) | | Definition date: | 2020-10-14 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | 6-{4-[3-(dimethylamino)propoxy]phenyl}-2-(methylsulfonyl)-N-[3-(1H-pyrazol-1-yl)propyl]pyrimidin-4-amine |
|
 | | WCV | | Name: | cyclopropyl[7-({2-[(prop-2-yn-1-yl)amino]pyrimidin-4-yl}amino)-3,4-dihydroquinolin-1(2H)-yl]methanone | | Formula: | C20 H21 N5 O | | SMILES: | c1nc(NCC#C)nc(c1)Nc2cc3c(cc2)CCCN3C(C4CC4)=O | | InChi: | InChI=1S/C20H21N5O/c1-2-10-21-20-22-11-9-18(24-20)23-16-8-7-14-4-3-12-25(17(14)13-16)19(26)15-5-6-15/h1,7-9,11,13,15H,3-6,10,12H2,(H2,21,22,23,24) | | Definition date: | 2020-10-14 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | cyclopropyl[7-({2-[(prop-2-yn-1-yl)amino]pyrimidin-4-yl}amino)-3,4-dihydroquinolin-1(2H)-yl]methanone |
|
 | | VYM | | Name: | (7-amino-3,4-dihydroquinolin-1(2H)-yl)(cyclopropyl)methanone | | Formula: | C13 H16 N2 O | | SMILES: | C(C1CC1)(=O)N3CCCc2ccc(cc23)N | | InChi: | InChI=1S/C13H16N2O/c14-11-6-5-9-2-1-7-15(12(9)8-11)13(16)10-3-4-10/h5-6,8,10H,1-4,7,14H2 | | Definition date: | 2020-09-22 | | Last modified: | 2020-12-04 | | Release date: | 2020-12-09 | | Identifier: | (7-amino-3,4-dihydroquinolin-1(2H)-yl)(cyclopropyl)methanone |
|